Phase 2 Study Subjects Show Weight Loss

Pharmachem has released the results of a double-blind, placebo-controlled study of 50 subjects, which showed that those taking Phase 2 lost nearly a half pound per week (3.8 lbs. over eight weeks), on average, or better than 200% more than those on placebo. There was also a 26-point drop in triglyceride levels, on average, for subjects taking Phase 2, or better than 300% more than those on placebo.